Is Syrup of Ipecac Still for Sale? Comparison of Pharmacies in a Large Urban Area

Abstract

There has been considerable publicity about the lack of benefit and potential dangers of syrup of ipecac. In November 2003, the American Academy of Pediatrics recommended against its use. Pharmacies in Houston, Texas were surveyed by telephone before (survey 1) and after (survey 2) the American Academy of Pediatrics' recommendation to determine whether ipecac availability changed. There were 126 pharmacies interviewed at survey 1, and 128 interviewed at survey 2. Pharmacies in survey 1 were more likely than those in survey 2 to sell ipecac (79% versus 64%, P < .01) and to have it in stock (75% versus 48%, P < .001). Pharmacies mostly stored ipecac on the shelves (67%, survey 1; 59%, survey 2, P = .27). Although syrup of ipecac availability has declined significantly, it is still available in more than 50% of pharmacies. Health care providers should advise against its use and advocate that pharmacies remove it.

Keywords

syrup of ipecac pharmacies poisoning

Get full access to this article

View all access options for this article.

References

American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position statement: ipecac syrup. J Toxicol Clin Toxicol. 1997;35:699-709.

Ipecac syrup. Vol. OTC 21 CFR 201.308; 1965.

Schiff RJ , Wurzel CL , Brunson SC , Kasloff I. , Nussbaum MP , Frank SD Death due to chronic ipecac use in a patient with bulimia. Pediatrics. 1986;78:412-416.

McClung HJ , Murray R. , Braden NJ , Fyda J. , Myers RP , Gutches L. Intentional ipecac poisoning in children. Am J Dis Child. 1988;142:637-639.

Bond GR Home syrup of ipecac use does not reduce emergency department use or improve outcome. Pediatrics. 2003;112:1061-1064.

Watson WA , Litovitz TL , Rodgers GC , et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005;23:589-666.

Krenzelok EP Ipecac syrup-induced emesis ... no evidence of benefit. Clin Toxicol (Phila). 2005;1:11-12.

Adler AG , Walinsky P. , Krall RA , Cho SY Death resulting from ipecac syrup poisoning. JAMA. 1980;243: 1927-1928.

Brotman MC , Forbath N. , Garfinkel PE , Humphrey JG Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa . Can Med Assoc J. 1981;125:453-454.

10.

Bennett HS , Spiro AJ , Pollack MA , Zucker P. Ipecac-induced myopathy simulating dermatomyositis. Neurology . 1982;32:91.

11.

Friedman EJ Death from ipecac intoxication in a patient with anorexia nervosa. Am J Psychiatry. 1984 ; 141:702-703.

12.

Mateer JE , Farrell BJ , Chou SS , Gutmann L. Reversible ipecac myopathy. Arch Neurol. 1985 ;42:188-189.

13.

Moldawsky RJ Myopathy and ipecac abuse in a bulimic patient . Psychosomatics. 1985;26:448-449.

14.

Palmer EP , Guay AT Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med. 1985;313:1457-1459.

15.

Dawson JA , Yager J. A case of abuse of syrup of ipecac resulting in death. J Am Coll Health. 1986;34:280-282.

16.

Rosenberg NL , Ringel SP Myopathy from surreptitious ipecac ingestion . West J Med. 1986 Sept;145:386-388.

17.

Friedman AG , Seime RJ , Roberts T. , Fremouw WJ Ipecac abuse: a serious complication in bulimia . Gen Hosp Psychiatry. 1987;9:225-228.

18.

Kuntzer T. , Bogousslavsky J. , Deruaz JP , Janzer R. , Regli F. Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy . J Neurol. 1989;236: 246-248.

19.

Dresser LP , Massey EW , Johnson EE , Bossen E. Ipecac myopathy and cardiomyopathy. J Neurol Neurosurg Psychiatry . 1993;56:560-562.

20.

Thyagarajan D. , Day BJ , Wodak J. , Gilligan B. , Dennett X. Emetine myopathy in a patient with an eating disorder. Med J Aust. 1993;159:757-760.

21.

Ho PC , Dweik R. , Cohen MC Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion . Clin Cardiol. 1998;21:780-783.

22.

Manno BR , Manno JE Toxicology of ipecac: a review. Clin Toxicol. 1977;10:221-242.

23.

McClung HJ , Murray R. , Braden NJ , Fyda J. , Myers RP , Gutches L. Intentional ipecac poisoning in children. Am J Dis Child. 1988;142:637-639.

24.

Berkner P. , Kastner T. , Skolnick L. Chronic ipecac poisoning in infancy: a case report. Pediatrics . 1988;82:384-386.

25.

Sutphen JL , Saulsbury FT Intentional ipecac poisoning: Munchausen syndrome by proxy. Pediatrics. 1988;82: 453-456.

26.

Colletti RB , Wasserman RC Recurrent infantile vomiting due to intentional ipecac poisoning. J Pediatr Gastroenterol Nutr. 1989;8:394-396.

27.

Day L. , Kelly C. , Reed G. Andersen JM , Keljo JM Fatal cardiomyopathy: suspected child abuse by chronic ipecac administration . Vet Hum Toxicol. 1989;31:255-257.

28.

Santangelo WC , Richey JE , Rivera L. , Fordtran JS Surreptitious ipecac administration simulating intestinal pseudo-obstruction. Ann Intern Med. 1989;110: 1031-1032.

29.

Johnson JE , Carpenter BL , Benton J. , Cross R. , Eaton LA Jr, Rhoads JM Hemorrhagic colitis and pseudomelanosis coli in ipecac ingestion by proxy . J Pediatr Gastroenterol Nutr. 1991;12:501-506.

30.

Goebel J. , Gremse DA , Artman M. Cardiomyopathy from ipecac administration in Munchausen syndrome by proxy . Pediatrics. 1993;92:601-603.

31.

Schneider DJ , Perez A. , Knilamus TE , Daniels SR , Bove KE , Bonnell H. Clinical and pathologic aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy. Pediatrics. 1996;97:902-906.

32.

Dershewitz RA , Niederman LG

Ipecac at home—a health hazard?

Clin Toxicol. 1981;18:969-972.

33.

Mofenson HC , Caraccio TR Benefits/risks of syrup of ipecac. Pediatrics.1986;77:551-552.

34.

Shannon M.

The demise of ipecac (commentary)

Pediatrics. 2003;112:1180-1181.

35.

American Academy of Pediatrics, Committee on Injury, Violence, and Poison Prevention. Poison treatment in the home. Pediatrics. 2003;112:1182-1185.

36.

Manoguerra AS , Cobaugh DJ , Guidelines for the Management of Poisoning Consensus Panel. Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons. Clin Toxical ( Phila). 2005;1:1-10.

37.

Pope HG , Hudson JI , Nixon RA , Herridge PL The epidemiology of ipecac abuse. New Engl J Med. 1986;314: 245-246.

38.

Humphries LL , Shirley PB , Piascik MT Ipecac misuse in clinical and non-clinical samples. Int J Eat Disord. 1992;11:361-367.

39.

Greenfeld D. , Mickley D. Quinlan DM , Roloff P. Ipecac abuse in a sample of eating disordered outpatients. Int J Eat Disord. 1993;13:411-414.

40.

Silber TJ

Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?

J Adolesc Health. 2005;37:256-260.

41.

Brushwood DB , Tietze KJ Regulatory controversy surrounding ipecac use and misuse. Am J Hosp Pharm. 1986;43:157-161.

42.

Morgan DL , Forrester MB Texas poisonings at the beginning of the 21st century: 2000 through 2002. Texas Med. 2005;101:72-78.

Is Syrup of Ipecac Still for Sale? Comparison of Pharmacies in a Large Urban Area—2003 Versus 2005

Abstract

Keywords

Get full access to this article

References